Coronary Artery Disease Screening in Kidney Transplant Candidates

NACompletedINTERVENTIONAL
Enrollment

144

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

February 28, 2019

Study Completion Date

July 31, 2019

Conditions
End Stage Renal DiseaseCoronary Artery Disease
Interventions
OTHER

Selective Screening

Patients randomized to selective-use of screening tests will not routinely undergo Myocardial Perfusion Scintography or Dobutamine Stress Echocardiography. If patients develop symptoms of CAD at any time, they will undergo investigations as per the usual standard of care.

Trial Locations (6)

Unknown

St. Paul's Hospital, Vancouver

Vancouver General Hospital, Vancouver

The Ottawa Hospital, Ottawa

University Health Network, Toronto

Royal Victoria Hospital, Montreal

L8N 4A6

St. Joseph's Healthcare Hamilton, Hamilton

All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

lead

University of British Columbia

OTHER

NCT02082483 - Coronary Artery Disease Screening in Kidney Transplant Candidates | Biotech Hunter | Biotech Hunter